Vergoeding 2018-2022 voor ATC-subgroep N07XX : Overige middelen werkzaam op het zenuwstelsel
- Raming voor de totale Zvw-populatie
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
N07XX02 Riluzol (Rilutek ®) | 462.920 | 955.810 | 990.320 | 979.820 | 995.780 |
N07XX04 Hydroxyboterzuur (Xyrem ®) | 3.417.700 | 3.781.800 | 4.044.700 | 3.506.000 | 3.182.500 |
N07XX05 Amifampridine (Firdapse ®) | 1.673.900 | 1.724.700 | 1.839.700 | 1.827.500 | 2.070.100 |
N07XX06 Tetrabenazine (Tetmodis ®) | 180.100 | 192.470 | 221.720 | 256.320 | 254.460 |
N07XX07 Fampridine (Fampyra ®) | 745.540 | 1.859.100 | 6.579.500 | 7.229.500 | 8.383.000 |
N07XX08 Tafamidis (Vyndaqel ®) | 2.514.700 | 3.486.900 | 3.879.500 | 3.545.500 | 26.855.300 |
N07XX11 Pitolisant (Wakix ®) | . | 266.470 | 1.081.400 | 1.170.100 | 1.301.200 |
Totaal | 8.994.860 | 12.267.250 | 18.636.840 | 18.514.740 | 43.042.340 |